Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;35(6):905-908.
doi: 10.1002/mds.28104. Epub 2020 May 28.

Outcome of Parkinson's Disease Patients Affected by COVID-19

Angelo Antonini  1 , Valentina Leta  2   3 , James Teo  2   4 , K Ray Chaudhuri  2   3
Affiliations

Outcome of Parkinson's Disease Patients Affected by COVID-19

Angelo Antonini et al. Mov Disord. 2020 Jun.
No abstract available

Keywords: COVID-19; Parkinson's disease; SARS-CoV-2.

PubMed Disclaimer

Comment in

References

    1. van Wamelen DJ, Leta V, Johnson J, et al. Drooling in Parkinson's disease: prevalence and progression from the Non‐motor International Longitudinal Study. Dysphagia 2020; 10.1007/s00455-020-10102-5 - DOI - PMC - PubMed
    1. Prasad S, Holla VV, Neeraja K, et al. Parkinson's disease and COVID‐19: perceptions and implications in patients and caregivers. Mov Disord 2020; 10.1002/mds.28088. - DOI - PMC - PubMed
    1. Helmich RC, Bloem BR. The Impact of the COVID‐19 pandemic on Parkinson's disease: hidden sorrows and emerging opportunities. J Parkinsons Dis 2020;10(2):351–354. - PMC - PubMed
    1. Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov Disord 1992;7(2):153–158. - PMC - PubMed
    1. Rodriguez‐Perez AI, Garrido‐Gil P, Pedrosa MA, et al. Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra. Brain Behav Iimmun 2019:S0889‐1591(19)31128‐6. - PubMed